semaglutide and anti inflammatory help with inflammation Semaglutide: What we know about safety cancer risk Frontiers The GLP-1 Analogs Liraglutide and

At week 72, the clinical data showed that 36.8% of patients receiving semaglutide achieved fibrosis improvement without worsening of NASH and 62.9% achieved NASH resolution without worsening of fibrosis, compared with 22.4% and 34.3%, respectively, in the placebo group (Sanyal et al., 2025)

Typically, patients of our weight loss program in San Luis Obispo, California who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise

While the idea of melting fat away with a stick-on patch is appealing, regulatory bodies like the Advertising Standards Authority have consistently found that these products dont deliver on their promises

The pharmaceutical giant, Eli Lilly has just launched its newly approved GLP-1 product, Zepbound, in a direct-to-consumer approach on its Lilly Direct

1052 Wang, S